| First Author | Matsumoto A | Year | 2018 |
| Journal | J Invest Dermatol | Volume | 138 |
| Issue | 7 | Pages | 1491-1500 |
| PubMed ID | 29474943 | Mgi Jnum | J:264080 |
| Mgi Id | MGI:6192840 | Doi | 10.1016/j.jid.2018.02.010 |
| Citation | Matsumoto A, et al. (2018) Attenuated Activation of Homeostatic Glucocorticoid in Keratinocytes Induces Alloknesis via Aberrant Artemin Production. J Invest Dermatol 138(7):1491-1500 |
| abstractText | Intense chronic itch significantly reduces quality of life for atopic dermatitis patients, impairing daily activity. Although abnormal itch sensation can be induced by innocuous stimuli, known as alloknesis, the mechanisms driving this process remain obscure. Psychological and environmental stimuli are known to aggravate atopic dermatitis symptoms. Recently, the enzyme 11beta-hydroxysteroid dehydrogenase-1 (HSD11beta1), which is expressed in keratinocytes, has been implicated in maintaining homeostasis against environmental stimuli by activating endogenous glucocorticoids. To investigate the role of HSD11beta1 in keratinocytes, we generated keratinocyte-specific Hsd11b1-knockout (Hsd11b1(KC-/-)) mice and analyzed skin phenotype. Hsd11b1(KC-/-) mice exhibited abnormal cutaneous innervation and skin sensitivity, including light mechanical stimulus-evoked itch (i.e., alloknesis). Attenuated endogenous glucocorticoid activation induced by aberrant artemin production in keratinocytes was involved in alloknesis in Hsd11b1(KC-/-) mice. Finally, we observed a significant negative correlation between expression of HSD11beta1 and artemin in human skin with and without AD. These results suggest that endogenous glucocorticoids that maintain skin homeostasis in the epidermis affect both skin innervation and cutaneous sensation. Modulation of HSD11beta1 activation could be a therapeutic target for sensitive or itchy skin. |
